Home › Bids
› Development of Biomarkers or Composite Biomarkers for Neurol
Development of Biomarkers or Composite Biomarkers for Neurological and Neuromuscular Disorders (R61/R33 - Clinical Trial Optional)
Open632 days leftHealthcaregrant
Oct 28, 2024
Jan 7, 2028 12:00 AM
Healthcare
grant
AI Summary
This grant opportunity (PAR-25-024) from NIH seeks applications for the development of biomarkers or composite biomarkers for neurological and neuromuscular disorders. It utilizes an R61/R33 phased award mechanism and allows for optional clinical trials.
Want the full details?
Sign up free to see the agency name, contact info, and the original bid posting link.